Correlation Between Silo Pharma and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Lumos Pharma, you can compare the effects of market volatilities on Silo Pharma and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Lumos Pharma.
Diversification Opportunities for Silo Pharma and Lumos Pharma
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Silo and Lumos is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Silo Pharma i.e., Silo Pharma and Lumos Pharma go up and down completely randomly.
Pair Corralation between Silo Pharma and Lumos Pharma
Given the investment horizon of 90 days Silo Pharma is expected to generate 10.28 times more return on investment than Lumos Pharma. However, Silo Pharma is 10.28 times more volatile than Lumos Pharma. It trades about 0.13 of its potential returns per unit of risk. Lumos Pharma is currently generating about -0.04 per unit of risk. If you would invest 117.00 in Silo Pharma on October 25, 2024 and sell it today you would earn a total of 79.00 from holding Silo Pharma or generate 67.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 56.67% |
Values | Daily Returns |
Silo Pharma vs. Lumos Pharma
Performance |
Timeline |
Silo Pharma |
Lumos Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Silo Pharma and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Silo Pharma and Lumos Pharma
The main advantage of trading using opposite Silo Pharma and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.Silo Pharma vs. Rezolute | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited | Silo Pharma vs. Inventiva Sa |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |